SparingVision

Developer of a medical therapy designed to treat Retinitis Pigmentosa which is part of Inherited Retinal Diseases. The company's offerings include a drug candidate to treat retinitis pigmentosa, the m...

Healthcare

Paris, France

Founded 2016

49 employees

Website

Valuation

$158.9M

Market implied

Share Price

N/A

Total Raised

$205M

Last Round

N/A

Investors

+16 other investors

View all 16 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock SparingVision's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required